|Bid||21.90 x 100|
|Ask||24.99 x 100|
|Day's Range||21.85 - 22.59|
|52 Week Range||7.20 - 27.09|
|PE Ratio (TTM)||-14.98|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||36.40|
NEW YORK, NY / ACCESSWIRE / July 17, 2017 / Sorrento Therapeutics had a big insider purchase revealed last week that helped drive share prices higher. Omeros Corporation also saw big gains after announcing ...
Bluebird bio, Omeros and two other companies are showing strong momentum.
Omeros Corp. said it plans legal action against an an anonymous detractor claiming to be a shareholder of the Seattle-based biotech company. Omeros said it doesn't typically respond to defamatory statements, but did so this case due to the egregious nature of the allegations. "This report is replete with falsehoods, misleading statements and incorrect analyses and conclusions," Omeros said in a news release .